Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7423541

N=C(N)NOCCCOc1ccc(C[C@H](NS(=O)(=O)c2ccc(Oc3c(Cl)cccc3[N+](=O)[O-])cc2)C(=O)O)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 5/20 0.43
ITGA2B P08514 5/20 0.43
MAPT P10636 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MCL1 Q07820 2/20 0.42
BCL2L1 Q07817 1/20 0.42
ITGB1 P05556 1/20 0.41
ITGA5 P08648 1/20 0.41
BCL2 P10415 2/20 0.41
F2 P00734 2/20 0.41
TMPRSS6 Q8IU80 2/20 0.41
POLB P06746 1/20 0.39
MMP2 P08253 2/20 0.39
PPARG P37231 1/20 0.39
MMP9 P14780 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
ADAMTS5 Q9UNA0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7463648 0.96 MAPT (0.46) ITGB3ITGA2BMAPTSMN1; SMN2MCL1
SCHEMBL7423552 0.91 MAPT (0.41) ITGB3ITGA2BMAPTSMN1; SMN2MCL1
Trifluoroacetic Acid SCHEMBL7414956 0.87 BCL2 (0.49) ITGB3ITGA2BMCL1BCL2
Trifluoroacetic Acid SCHEMBL7414945 0.85 ITGB3 (0.52) ITGB3ITGA2BF2TMPRSS6MMP2
Trifluoroacetic Acid SCHEMBL7415034 0.84 ITGB3 (0.47) ITGB3ITGA2BF2TMPRSS6PPARG
Trifluoroacetic Acid SCHEMBL7414429 0.84 MMP2 (0.52) ITGB3ITGA2BF2TMPRSS6MMP2
Trifluoroacetic Acid SCHEMBL7415321 0.83 ITGB1 (0.49) ITGB3ITGA2BITGB1ITGA5F2
Trifluoroacetic Acid SCHEMBL7417586 0.83 ITGB3 (0.59) ITGB3ITGA2BF2TMPRSS6MMP2
Trifluoroacetic Acid SCHEMBL7413027 0.83 MAPT (0.45) ITGB3ITGA2BMAPTMCL1BCL2L1
Trifluoroacetic Acid SCHEMBL7412090 0.83 ITGB3 (0.47) ITGB3ITGA2BF2TMPRSS6L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6344484-B1 TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-02-05 US disclosed
EP-1159262-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2001-12-05 EP disclosed
WO-2000047552-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2000-08-17 WO disclosed